Skip to main content
. 2022 May 26;226(10):1790–1799. doi: 10.1093/infdis/jiac135

Figure 1.

Figure 1.

Kaplan–Meier estimates for the primary endpoint of time to alleviation of 6 influenza symptoms and resolution of fever in US316 (A) and US317 (B). The estimated probability of persistence of symptoms (failure to have achieved alleviation) as a function of time (hours) from the start of dosing is shown.